Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS, FVT

Together with Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024


PALO ALTO, Calif., May 2, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting, which will take place from May 3 to 7 in Glasgow, Scotland.

With over 24 million new cancer cases expected by 2030, accessible, high-quality cancer treatment is crucial to improving patient outcomes1. Radiotherapy is an integral part of therapeutic treatments for approximately 50% of the patients diagnosed with cancer, yet many countries have inadequate availability of radiotherapy treatment2. Varian is working in collaboration with healthcare providers to change that statistic by creating innovative and integrated solutions to help bring treatment options to those communities who need it most.

"As part of Siemens Healthineers, Varian is in a unique position to develop cutting-edge products and solutions that bridge the care gap globally," remarked Arthur Kaindl, Head of Varian. "By combining the expertise of the leading imaging and radiotherapy companies, we have the ability to achieve much more than any individual cancer care company by driving connection throughout the entire care continuum."

At the ESTRO meeting, Varian will present a range of solutions that will enhance the care continuum, including:

Varian is committed to generating evidence that can help improve patient outcomes and expand access to care. This commitment is evident through its efforts to elevate the standard of care, which will be showcased at ESTRO through numerous oral, panel, customer use cases, and poster presentations. These presentations, which include products such as Ethos and HyperSight imaging, will contribute to the growing body of clinical evidence and data across various treatment domains, further reinforcing Varian's dedication to enhancing patient care. 

VARIAN, HYPERSIGHT, ETHOS, HALCYON, EDGE, TRUEBEAM, ARIA CORE, and IDENTIFY are trademarks of Varian Medical Systems, Inc., pending or registered U.S. Pat. & Tm. Off. MAGNETOM Free.Max, SOMATOM go.Sim, and SOMATOM go.Open Pro are trademarks of Siemens Healthcare GmbH registered U.S. Pat. & Tm. Off.

About Varian
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey ? from screening to survivorship. From advanced imaging and radiation therapy, to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com

Press Contact
Kristin Corey
Varian Corporate Communications
[email protected] 

1 Cancer Tomorrow | IARC - https://gco.iarc.who.int
2 M Abdel-Wahab, et al. JCO Global Oncol. 2021(7):827-842.


These press releases may also interest you

at 00:23
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for May 17, 2024. OKX to...

at 00:10
Innovative technology brand TECNO confirmed that its newest smartphone, the CAMON 30 Series, will receive an outstanding 3 years of Android upgrades (extending to Android 16), along with 3 years of security patch support. This update aims to provide...

at 00:10
Pixfra Technology's 2024 launch, the Mile 2: New Miles to Go, has won the German Red Dot Design Award. This advanced thermal monocular is crafted for outdoor use, search and rescue, and hunting, setting new precision standards with its minimalist...

at 00:05
Corsearch, leading provider of brand protection and trademark solutions, has today shared research predicting that the size of the global trade in counterfeit goods could reach $1.79 trillion by 2030, a 75% increase from that of 2023 and a growth 3.6...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 16, 2024. OKX Launches Cryptopedia Season 18, Offering Users Up to...



News published on and distributed by: